Immunology: Autoimmunity Flashcards
Type II autoimmunity
IgG
cell surface/ECM antigens
Type III autoimmunity
IgG
immune complex deposition
Type IV autoimmunity
mediated by T cells
autoimmune hemolytic anemia
type II (IgG and IgM): Rh blood group or I antigen
destruction of RBC by classical complement (MAC and C3b) and phagocytes (with Fc receptor (IgG) or C3b)
anemia
Dx: Direct Coomb’s
Tx: corticosteroids
autoimmune thrombocytopenia purpura
type II: platelet integrin, gpIIb:IIIa
inhibition of enzyme that cleaves vWF (links platelets and vessels with clots) = excessive platelet adhesions (occlude small vessels)
damage: kidney, liver, brain
abnormal bleeding, neurological symptoms, low platelets, bruises
Dx: microangioplastic hemolytic anemia
Tx: plasmaphoresis
Goodpasture’s syndrome
type II: collagen type IV of BM
classical (then alternative) complement and phagocytes cause damage
glomerulonephritis, pulmonary hemorrhage
symptoms: loss of appetite, weakness, fatigue
Dx: anti-GBM
Tx: plasma exchange and antiinflammatory drugs
pemphigus vulgaris
type II: epidermal cadhedrin: proteins desmoglein 1 and 3
blistering of skin
Dx: punch biopsy of lesion with immunofluorescent stain (IgG4 Ab = pathogenic)
Tx: corticosteroids, anti-inflammatory drugs, rituximab
acute rheumatic fever
type II: GAS (S. pyogenes) cell wall antigens; molecular mimicry (Ab cross-react with cardiac muscle)
arthritis, myocarditis, late scarring of heart valves
symptoms: chest pain, shortness of breath, fever, joint pain, endocarditis
Grave’s disease
type II: TSH receptor (agonist)
hyperthyroidism
symptoms: heat intolerance, nervous, irritable, warm moist skin, weight loss, enlarged thyroid, bulging eyes, characteristic start (eye muscle inflammation)
Pregnant women: pass IgG to fetus and fetus will have condition
Tx fetus: plasmaphoresis to remove Ab and thyroid function is restored
Myasthenia gravis
type II: Ach receptor (antagonist: endocytosed and degraded)
progressive weakness
symptoms: facial muscles (esp. eyes and eyelids) first: diplopia, ptosis; progresses to generalized muscle weakness
Tx: anti-inflammatory, pyridostigmine
Type 2 diabetes (insulin-resistant diabetes)
type II: insulin receptor (antagonist)
hyperglycemia, ketoacidosis
Hypoglycemia
type II: insulin receptor (agonist)
hypoglycemia
Scleroderma
type II: destruction of vascular endothelial cells of arterioles and sm. muscle cells; replaced with collagen and fibrous material
localized or systemic symmetrical skin thickening; hard, smooth, ivory skin
damage: kidney, vessels, liver, brain
Dx: ANA (anti-nuclear Ab), ATA (anti-topoisomerase Ab), ACA (anti-centromere Ab)
Tx: increase blood flow to extremities
rituximab
B cell marker CD20 specific mAb: Ab results in NK ADCC to B cells
Tx: pemphigus vulgaris and RA (doesn’t make sense if T cell mediated)
pyridostigmine
inhibits cholinesterase
Tx: myasthenia gravis